Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SCRX

Sciele Pharma (MM) (SCRX)

Sciele Pharma (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCRX
DateTimeSourceHeadlineSymbolCompany
26/08/202103:00Business WiretheScore Bet Becomes Official Gaming Partner of Golf Canada and its Marquee Golf Championships, the RBC Canadian Open and CP Women’s OpenNASDAQ:SCRXSciele Pharma (MM)
20/08/202100:00Business WiretheScore Selects Toronto’s Waterfront Innovation Centre as Site for New, Expansive HeadquartersNASDAQ:SCRXSciele Pharma (MM)
05/08/202121:01Business WirePenn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology CompanyNASDAQ:SCRXSciele Pharma (MM)
14/07/202107:01Business WiretheScore Reports F2021 Q3 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
06/07/202121:30Business WiretheScore to Report Q3 F2021 Financial Results on Tuesday, July 13, 2021NASDAQ:SCRXSciele Pharma (MM)
23/06/202106:16Business WiretheScore Applauds Passage by the Senate of Historic Legislation to Legalize Single Event Sports Betting in CanadaNASDAQ:SCRXSciele Pharma (MM)
23/04/202109:41Business WiretheScore Issues Statement Following the Passing of Bill C-218 by the House of CommonsNASDAQ:SCRXSciele Pharma (MM)
14/04/202107:02Business WiretheScore Reports Record F2021 Q2 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
06/04/202121:45Business WiretheScore To Report Q2 F2021 Financial Results on Tuesday, April 13, 2021NASDAQ:SCRXSciele Pharma (MM)
31/03/202104:02Business WirePGA TOUR Announces theScore Bet as an Official Betting OperatorNASDAQ:SCRXSciele Pharma (MM)
29/03/202123:30Business WiretheScore Secures Market Access for Mobile Sports Betting in Illinois Through Agreement with Caesars EntertainmentNASDAQ:SCRXSciele Pharma (MM)
02/03/202103:04Business WiretheScore Announces Closing of US$186.3 Million Initial Public Offering in the United StatesNASDAQ:SCRXSciele Pharma (MM)
10/10/200808:01Business WireShionogi Completes Acquisition of ScieleNASDAQ:SCRXSciele Pharma (MM)
10/10/200802:10Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
09/10/200823:02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
09/10/200822:30Business WireShionogi and Sciele Announce Completion of Subsequent Offering PeriodNASDAQ:SCRXSciele Pharma (MM)
07/10/200800:54Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
06/10/200821:30Business WireShionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent OfferingNASDAQ:SCRXSciele Pharma (MM)
06/10/200821:05Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
01/10/200823:45Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
26/09/200809:38PR Newswire (US)Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. IndicesNASDAQ:SCRXSciele Pharma (MM)
19/09/200823:44Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
19/09/200820:08Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
19/09/200820:00Business WireShionogi and Sciele Announce Receipt of United States Antitrust ClearanceNASDAQ:SCRXSciele Pharma (MM)
16/09/200823:46Business WireSciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe DroolingNASDAQ:SCRXSciele Pharma (MM)
09/09/200801:19Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
09/09/200801:03Edgar (US Regulatory)Sciele Pharma, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:SCRXSciele Pharma (MM)
04/09/200806:49Edgar (US Regulatory)Sciele Pharma, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:SCRXSciele Pharma (MM)
04/09/200806:47Edgar (US Regulatory)Sciele Pharma, Inc. - Current report filing (8-K)NASDAQ:SCRXSciele Pharma (MM)
03/09/200806:58Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
 Showing the most relevant articles for your search:NASDAQ:SCRX